The global metagenomic sequencing market is forecasted to reach USD 6,899 million by 2030, experiencing a compound annual growth rate (CAGR) of 20.0% during this period. The rapid expansion of this technology is largely driven by its decreasing costs. Its increasing use in agricultural biotechnology, which allows comprehensive genome analysis from environmental samples without the need for cultivation, is also contributing to this growth.
Advanced sequencing techniques offer numerous advantages over traditional methods. The demand for these technologies in the life sciences industry is rising due to their accuracy and faster turnaround times.
Moreover, the growing prevalence of infectious diseases such as viral diarrhea, influenza, hepatitis B, and HIV/AIDS, coupled with an increasing number of gene discoveries, is prompting biotechnology firms and academic institutions to conduct more metagenomic studies.
In recent years, the drug discovery segment accounted for over 26% of the market revenue and is expected to maintain its leading position throughout the forecast period. This is largely due to the rising research efforts in biotechnology and pharmaceutical industries to discover new drugs, often in collaboration with key market players and academic institutions.
Download free sample copy of this report: https://www.psmarketresearch.com/market-analysis/metagenomic-sequencing-market/report-sample
The shotgun sequencing method held the largest share of the market and is expected to continue leading throughout the forecast period. Its dominance is attributed to the method’s advantages over others and the growing number of genomics-based research activities driven by academic and research institutions.
In recent years, North America has led the market, capturing more than 42% of the global revenue. The continent is expected to maintain its dominance, driven by significant R&D efforts in biotechnology and pharmaceuticals, a high prevalence of diseases, the presence of established healthcare companies, and strong support for new research and development facilities.
Additionally, the early adoption of novel technologies, the rising prevalence of chronic diseases, and the growing use of genomics in genetic research and diagnostics are supporting market growth in North America. The availability of substantial research funding and advanced next-generation sequencing (NGS) data analysis tools further propels the market in the region.
Europe is also witnessing significant growth, driven by the presence of leading research institutions and industry participants. The collaboration between government bodies and sequencing solution providers is contributing to market expansion. The availability of advanced genomic sequencing technologies is further boosting the industry’s progress in Europe.
About P&S Intelligence
P&S Intelligence offers custom and syndicated market research and consulting services to clients across the globe. Our team of young and dynamic researchers, guided by mentors with years of experience, create data-rich reports tailored to the needs of MNCs as well as startups and SMEs. We remain in a perennial quest to offer exhaustive insights into every aspect of the market, allowing businesses of all sizes to seize even the smallest of opportunities and tackle even the biggest of challenges.
Contact:
Chandra Mohan
AVP - Business Development
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Comments